Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy for Treatment of Calcium Channel Blockers, Angiotensin II Receptor Blockers, and Metformin Overdose
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
An overdose of antihypertensive agents, such calcium channel blockers (CCBs) and angiotensin II receptor blocker (ARBs), and the antihyperglycemic agent, metformin, leads to hypotension and lactic acidosis, respectively. A 40-year-old hypertensive and diabetic man with hyperlipidemia and a weight of 110 kg presented to the emergency room with vomiting, dizziness, and hypotension following an attempted drug overdose suicide with combined CCBs, ARBs, 3-hydroxy-3-methylglutaryl-coemzyme A reductase inhibitors, and metformins. A conventional medical treatment initially administered proved ineffective. The treatment was then changed to simultaneous extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT), which was effective. This shows that simultaneous ECMO and CRRT can be an effective treatment protocol in cases of ineffective conventional medical therapy for hypotension and lactic acidosis due to an overdose of antihypertensive agents and metformin, respectively.
Abstract
An overdose of antihypertensive agents, such calcium channel blockers (CCBs) and angiotensin II receptor blocker (ARBs), and the antihyperglycemic agent, metformin, leads to hypotension and lactic acidosis, respectively. A 40-year-old hypertensive and diabetic man with hyperlipidemia and a weight of 110 kg presented to the emergency room with vomiting, dizziness, and hypotension following an attempted drug overdose suicide with combined CCBs, ARBs, 3-hydroxy-3-methylglutaryl-coemzyme A reductase inhibitors, and metformins. A conventional medical treatment initially administered proved ineffective. The treatment was then changed to simultaneous extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT), which was effective. This shows that simultaneous ECMO and CRRT can be an effective treatment protocol in cases of ineffective conventional medical therapy for hypotension and lactic acidosis due to an overdose of antihypertensive agents and metformin, respectively.
참고문헌 (24)
- Abernethy DR, "Calcium-antagonist drugs", N Engl J Med, 341, pp.1447~1457 (1999)
- Tsoi B, "Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension : Systematic Review and Network Meta-Analysis of Randomised Controlled Trials", Heart Lung Circ, 27, pp.666~682 (2018)
- James PA, "2014 evidence-based guideline for the management of high blood pressure in adults : report from the panel members appointed to the Eighth Joint National Committee(JNC 8)", JAMA, 311, pp.507~520 (2014)
- Sirtori CR, "Re-evaluation of a biguanide, metformin:mechanism of action and tolerability", Pharmacol Res, 30, pp.187~228 (1994)
- St-Onge M, "Experts consensus recommendations for the management of calcium channel blocker poisoning in adults", Crit Care Med, 45, pp.e306~e315 (2017)
- Eisenberg MJ, "Calcium channel blockers : an update", Am J Med, 116, pp.35~43 (2004)
- Bologa C, "Lipid emulsion therapy in cardiodepressive syndrome after diltiazem overdose-case report", Am J Emerg Med, 31, pp.1154~ (2013)
- Boyer EW, "Treatment of calcium-channel-blocker intoxication with insulin infusion", N Eng J Med, 344, pp.1721~1722 (2001)
- Bailey CJ, "Metformin", N Engl J Med, 334, pp.574~579 (1996)
- Seidowsky A, "Metformin-associated lactic acidosis : a prognostic and therapeutic study", Crit Care Med, 37, pp.2191~2196 (2009)
- DeFronzo R, "Metforminassociated lactic acidosis : Current perspectives on causes and risk", Metabolism, 65, pp.20~29 (2016)
- Vecchio S, "Metformin accumulation : lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66patients on chronic therapy", Clin Toxicol(Phila), 52, pp.129~135 (2014)
- Bailey CJ, "Effect of metformin on glucose metabolism in the splanchnic bed", Br J Pharmacol, 105, pp.1009~1013 (1992)
- Calello DP, "Extracorporeal treatment for metformin poisoning : systematic review and recommendations from the extracorporeal treatments in poisoning workgroup", Crit Care Med, 43, pp.1716~1730 (2015)
- Macedo E, "Continuous dialysis therapies : Core curriculum 2016", Am J Kidney Dis, 68, pp.645~657 (2016)
- Keller G, "Management of metformin-associated lactic acidosis by continuous renal replacement therapy", Plos One, 6, pp.e23200~ (2011)
- Laine K, "Prevention of amlodipine absorption by activated charcoal : effect of delay in charcoal administration", Br J Clin Pharmacol, 43, pp.29~33 (1997)
- Tintinalli JE, "Emergency medicine: A comprehensive study guide", pp.1294~1295 (2016), McGraw-Hill
- Raeble MA, "Hyperkalemia associated with use of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers", Cardiovasc Ther, 30, pp.e156~e166 (2012)
- Celotto AC, "Effects of acid-base imbalance on vascular reactivity", Braz J Med Biol Res, 41, pp.439~445 (2008)
- Levy B, "Vasoplegia treatments: the past, the present, and the future", Crit Care, 22, pp.52~ (2018)
- Vignesh C, "Extracorporeal membrane oxygenation in drug overdose : A clinical case series", Indian J Crit Care Med, 22, pp.111~115 (2018)
- Weinberg RL, "Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose", Perfusion, 29, pp.53~56 (2014)
- Vincent JL, "The role of hypotension in the development of acute renal failure", Nephrol Dial Transplant, 24, pp.337~338 (2009)